Skip to main content
Scheme 1 | Journal of Nanobiotechnology

Scheme 1

From: GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy

Scheme 1

Schematic illustration composition of LND@Fe3O4@MONs-PEG (LFMP) and the therapeutic mechanism of LFMP. A Displaying the preparation process and nanostructure of LFMP. B The GSH responsive behavior of LFMP and its multiple anti-tumor effects by disrupting redox homeostasis, interfering with tumor cell metabolism, and triggering ferroptosis

Back to article page